Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)Recruiting
NCT07575932Phase 2Updated Aug 17, 2026
Sponsor: Pfizer
Overweight · Obesity · Overweight and/or Obesity · Overweight or Obesity
United States, Canada
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal CancerRecruiting
NCT07392892Phase 2, Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma · Metastatic Gastric Cancer · Gastroesophageal Junction Cancer · Esophageal Adenocarcinoma
United States, China, Israel, Italy, Japan +3 more
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal CancerRecruiting
NCT07222800Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Intestinal Neoplasms · Gastrointestinal Neoplasms · Digestive System Neoplasms · Neoplasms by Site
United States, Argentina, Australia, Belgium, Brazil +12 more
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic DisordersRecruiting
NCT04398628N/AUpdated Aug 17, 2026
Sponsor: American Thrombosis and Hemostasis Network
Hematologic Disorder · Bleeding Disorder · Connective Tissue Disorder · Hemophilia
United States
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung CancerRecruiting
NCT07476287Phase 2Updated Aug 17, 2026
Sponsor: Pfizer
Small Cell Lung Cancer · Small Cell Lung Cancer ( SCLC ) · Transformed Small Cell Lung Cancer · Lung Neoplasms
United States, Brazil, China, France, Hong Kong +5 more
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial CancerNot Yet Recruiting
NCT07578649Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Endometrial Neoplasms · Endometrial Cancer
Japan
A Study to Learn About the Safety of PENBRAYA During PregnancyRecruiting
NCT07768163N/AUpdated Aug 17, 2026
Sponsor: Pfizer
Meningococcal Disease
United States
Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.Recruiting
NCT06899204N/AUpdated Aug 17, 2026
Sponsor: Pfizer
Atopic Dermatitis · Atopic Dermatitis, Unspecified · Dermatitis, Atopic
United States
A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19Terminated
NCT05386472Phase 1Updated Aug 17, 2026
Sponsor: Pfizer
COVID-19
United States
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLCRecruiting
NCT07489066Phase 2Updated Aug 17, 2026
Sponsor: Pfizer
Carcinoma · Non-Small-Cell Lung · Lung Cancer (NSCLC) · Lung Neoplasms
United States, China, Israel, Puerto Rico, Taiwan
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial CancerRecruiting
NCT07421700Phase 1, Phase 2Updated Aug 17, 2026
Sponsor: Pfizer
Urothelial Cancer · Advanced/Metastatic Urothelial Cancer · Urothelial Carcinoma
United States, Australia, China, Japan, Puerto Rico +1 more
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.Recruiting
NCT07227012Phase 1, Phase 2Updated Aug 17, 2026
Sponsor: Pfizer
Carcinoma, Hepatocellular · Hepatocellular Cancer · Hepatocellular Carcinoma · Unresectable Hepatocellular Carcinoma
United States, Japan, Puerto Rico, Taiwan
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerRecruiting
NCT07222566Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Advanced Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung (NSCLC)
United States, Argentina, Australia, Brazil, Canada +15 more
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung CancerRecruiting
NCT07226999Phase 2, Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Small Cell Lung Cancer (SCLC)
United States, Australia, China, France, Germany +5 more
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of MigraineRecruiting
NCT04743141Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Acute Treatment of Migraine
United States, Poland, Spain
Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia BCompleted
NCT03938792Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Hemophilia A · Hemophilia B
United States, Bulgaria, Canada, China, Croatia +15 more
A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.Recruiting
NCT06587035N/AUpdated Aug 14, 2026
Sponsor: Pfizer
Dwarfism, Pituitary
India
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe DiseaseRecruiting
NCT06679140Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
COVID-19 SARS-CoV-2 Infection
United States, Argentina, Belgium, Brazil, Bulgaria +14 more
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALLRecruiting
NCT05748171Phase 2Updated Aug 14, 2026
Sponsor: Pfizer
ACUTE LYMPHOBLASTIC LEUKEMIA
Austria, Belgium, Czechia, Denmark, Finland +11 more
A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19Completed
NCT07089680N/AUpdated Aug 14, 2026
Sponsor: Pfizer
Coronavirus Disease 2019 (COVID-19)
South Korea
PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular RosaceaTerminated
NCT06013371Phase 2Updated Aug 14, 2026
Sponsor: Icahn School of Medicine at Mount Sinai
Seborrheic Dermatitis · Papulopustular Rosacea
United States
Randomized Study in Children and Adolescents With Migraine: Acute TreatmentRecruiting
NCT04649242Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Pediatric Migraine
United States, Canada, China, Japan, Mexico +4 more
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single DoseRecruiting
NCT06866405Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
RSV Infection
United States, Argentina, South Africa, The Gambia
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.Recruiting
NCT07028853Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Metastatic Castration Sensitive Prostate Cancer (mCSPC) · Hormone Sensitive Prostate Cancer · Prostate Cancer · Cancer of the Prostate
United States, Argentina, Australia, Belgium, Brazil +21 more
A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreFRecruiting
NCT07653100Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Respiratory Syncytial Virus (RSV)
India

Previous page Next page